Sun gets USFDA nod for generic heart disease drug

eHEALTH BureauDrug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.The company’s US subsidiary has bagged a tentative approval for its abbreviated new drug application (ANDA) to market a generic version of IPR Pharmaceutical’s Crestor tablets in strengths of 5 mg, 10 mg, 20 mg and 40 mg, Sun Pharma said in a statement.Crestor has annual sales of nearly US $3.4 billion in the US market. The generic Rosuvastatin tablets contain Rosuvastatin Calcium in strengths of 5 mg, 10 mg, 20 mg and 40 mg, it said.The tablets are indicated in patients suffering with heart diseases like pertriglyceridemia and patients with homozygous familial hypercholesterolemia.

Click to comment

Leave a Reply

Your email address will not be published.

Most Popular





Get Heard Portal


eHealth Event Report



To Top